Comparison of the bone protective effects of an isoflavone-rich diet with dietary and subcutaneous administrations of genistein in ovariectomized rats

Toxicology Letters

Volumn 184, Issue 3, 2009, Pages 198-203

  Hertrampf, T ^a   Schleipen, B ^a   Offermanns, C ^a   Velders, M ^a   Laudenbach, U ^a   Diel, P ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Biochemical bone markers; Bone mineral density; Estrogens; Genistein; Isoflavones

Indexed keywords

COLLAGEN TYPE 1; DAIDZEIN; ESTRADIOL; GENISTEIN; ISOFLAVONE; OSTEOCALCIN; OSTEOPONTIN; PYRIDINOLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ANIMALS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; COLLAGEN TYPE I; DIET; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; GENISTEIN; INJECTIONS, SUBCUTANEOUS; ORGAN SIZE; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; OSTEOPOROSIS; OVARIECTOMY; PEPTIDES; PHYTOESTROGENS; RATS; RATS, WISTAR; TIBIA; UTERUS;

ANIMALIA; RATTUS;

EID: 58649096568     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.11.006     Document Type: Article

References (47)

1. Allen M.J. Biochemical markers of bone metabolism in animals: uses and limitations. Vet. Clin. Pathol. 32 3 (2003) 101-113
2. Anderson J.J., Ambrose W.W., and Garner S.C. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc. Soc. Exp. Biol. Med. 217 3 (1998) 345-350
3. Ashby J. Testing for endocrine disruption post-EDSTAC: extrapolation of low dose rodent effects to humans. Toxicol. Lett. 120 1-3 (2001) 233-242 31
4. Beral V., Million Women Study Collaborators, 2003. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362 (9382), 419-427. Erratum in: Lancet 362 (9390), 1160.
5. Blaut M., Schoefer L., and Braune A. Transformation of flavonoids by intestinal microorganisms. Int. J. Vitam. Nutr. Res. 73 2 (2003) 79-87
6. Branca F. Dietary phyto-oestrogens and bone health. Proc. Nutr. Soc. 62 4 (2003) 877-887
7. Butler W.T. The nature and significance of osteopontin. Connect. Tissue Res. 23 2-3 (1989) 123-136
8. Cassidy A. Potential risks and benefits of phytoestrogen-rich diets. Int. J. Vitam. Nutr. Res. 73 2 (2003) 120-126
9. Cassidy A., Brown J.E., Hawdon A., Faughnan M.S., King L.J., Millward J., Zimmer-Nechemias L., Wolfe B., and Setchell K.D. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J. Nutr. 136 1 (2006) 45-51
10. Coleman R.E. The clinical use of bone resorption markers in patients with malignant bone disease. Cancer 94 10 (2002) 2521-2533
11. Cos P., De Bruyne T., Apers S., Vanden Berghe D., Pieters L., and Vlietinck A.J. Phytoestrogens: recent developments. Planta Med. 69 7 (2003) 589-599
12. Davis S.R., Dalais F.S., Simpson E.R., and Murkies A.L. Phytoestrogens in health and disease. Recent Prog. Horm. Res. 54 (1999) 185-210
13. Degen G.H., Janning P., Diel P., and Bolt H.M. Estrogenic isoflavones in rodent diets. Toxicol. Lett. 128 (2002) 145-157
14. Denhardt D.T., and Noda M. Osteopontin expression and function: role in bone remodelling. J. Cell. Biochem. Suppl. 30-31 (1998) 92-102
15. Diel P., Smolnikar K., Schulz T., Laudenbach-Leschowski U., Michna H., and Vollmer G. Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Hum. Reprod. 16 5 (2001) 997-1006
16. Diel P., Hertrampf T., Seibel J., Laudenbach-Leschowsky U., Kolba S., and Vollmer G. Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats. J. Steroid. Biochem. Mol. Biol. 102 1-5 (2006) 60-70
17. Ebeling P.R., Peterson J.M., and Riggs B.L. Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases. J. Bone Miner. Res. 7 11 (1992) 1243-1250
18. Fitzpatrick L.A. Phytoestrogens-mechanism of action and effect on bone markers and bone mineral density. Endocrinol. Metab. Clin. North Am. 32 1 (2003) 233-252 viii
19. Fitzpatrick L.A. Estrogen therapy for postmenopausal osteoporosis. Arq. Bras. Endocrinol. Metabol. 50 4 (2006) 705-719
20. Gambacciani M., Ciaponi M., and Genazzani A.R. The HRT misuse and osteoporosis epidemic: a possible future scenario. Climacteric. 10 4 (2007) 273-275
21. Hadjidakis D.J., and Androulakis I.I. Bone remodelling. Ann. N. Y. Acad. Sci. 1092 (2006) 385-396
22. Hertrampf T., Schmidt S., Laudenbach-Leschowsky U., Seibel J., and Diel P. Tissue-specific modulation of cyclooxygenase-2 (Cox-2) expression in the uterus and the v. cava by estrogens and phytoestrogens. Mol. Cell. Endocrinol. 243 1-2 (2005) 51-57
23. Hertrampf T., Degen G.H., Kaid A.A., Laudenbach-Leschowsky U., Seibel J., Di Virgilio A.L., and Diel P. Combined effects of physical activity, dietary isoflavones and 17beta-estradiol on movement drive, body weight and bone mineral density in ovariectomized female rats. Planta Med. 72 6 (2006) 484-487
24. Hertrampf T., Gruca M.J., Seibel J., Laudenbach U., Fritzemeier K.H., and Diel P. The bone-protective effect of the phytoestrogen Genistein is mediated via ERα-dependent mechanisms and strongly enhanced by physical activity. Bone 40 6 (2007) 1529-1535
25. Hertrampf, T., Schleipen, B., Velders, M., Laudenbach, U., Fritzemeier, K.H., Diel, P., 2008. Estrogen receptor subtype-specific effects on markers of bone homeostasis. Mol. Cell. Endocrinol. 10;291 (1-2), 104-108.
26. Ishida H., Uesugi T., Hirai K., Toda T., Nukaya H., Yokotsuka K., and Tsuji K. Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol. Pharm. Bull. 21 1 (1998) 62-66
27. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 3 (1997) 863-870
28. Lee Y.B., Lee H.J., Kim K.S., Lee J.Y., Nam S.Y., Cheon S.H., and Sohn H.S. Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats. Biosci. Biotechnol. Biochem. 68 5 (2004) 1040-1045
29. Lerner U.H. Bone remodeling in post-menopausal osteoporosis. J. Dent. Res. 85 7 (2006) 584-595
30. Li B., and Yu S. Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. Biol. Pharm. Bull. 26 6 (2003) 780-786
31. Lindsay R., Hart D.M., Aitken J.M., MacDonald E.B., Anderson J.B., and Clarke A.C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1 7968 (1976) 1038-1041
32. Mathey J., Mardon J., Fokialakis N., Puel C., Kati-Coulibaly S., Mitakou S., Bennetau-Pelissero C., Lamothe V., Davicco M.J., Lebecque P., Horcajada M.N., and Coxam V. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol. Osteoporos. Int. 18 5 (2007) 671-679
33. Nakajima D., Kim C.S., Oh T.W., Yang C.Y., Naka T., Igawa S., and Ohta F. Suppressive effects of genistein dosage and resistance exercise on bone loss in ovariectomized rats. J. Physiol. Anthropol. Appl. Human Sci. 20 5 (2001) 285-291
34. Picherit C., Coxam V., Bennetau-Pelissero C., Kati-Coulibaly S., Davicco M.J., Lebecque P., and Barlet J.P. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J. Nutr. 130 7 (2000) 1675-1681
35. Pie J.E., Park J.H., Park Y.H., Ryu Y.M., Kim K.N., Suh S.W., Becker K.G., Cho-Chung Y.S., and Kim M.K. Effect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarray. J. Nutr. Biochem. 17 3 (2006) 157-164
36. Pelissero C., Bennetau B., Babin P., Le Menn F., and Dunogues J. The estrogenic activity of certain phytoestrogens in the Siberian sturgeon Acipenser baeri. J. Steroid. Biochem. Mol. Biol. 38 3 (1991) 293-299
37. Schmidt S., Degen G.H., Seibel J., Hertrampf T., Vollmer G., and Diel P. Hormonal activity of combinations of genistein, bisphenol A and 17beta-estradiol in the female Wistar rat. Arch Toxicol. 80 12 (2006) 839-845
38. Setchell K.D., and Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 129 3 (1999) 758S-767S
39. Setchell K.D., and Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am. J. Clin. Nutr. 78 Suppl. 3 (2003) 593S-609S
40. Shiguemoto, G.E., Rossi, E.A., Baldissera, V., Gouveia, C.H., de Valdez Vargas, G.M., de Andrade Perez, S.E., 2007. Isoflavone-supplemented soy yoghurt associated with resistive physical exercise increase bone mineral density of ovariectomized rats. Maturitas 20;57 (3), 261-270.
41. Sodek J., Ganss B., and McKee M.D. Osteopontin. Crit. Rev. Oral. Biol. Med. 11 3 (2000) 279-303
42. Stevenson J.C. Hormone replacement therapy: review, update, and remaining questions after the Women's Health Initiative Study. Curr. Osteoporos. Rep. 2 1 (2004) 12-16
43. Thiede M.A., Smock S.L., Petersen D.N., Grasser W.A., Thompson D.D., and Nishimoto S.K. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology 135 3 (1994) 929-937
44. Wade M.G., Lee A., McMahon A., Cooke G., and Curran I. The influence of dietary isoflavone on the uterotrophic response in juvenile rats. Food Chem. Toxicol. 41 11 (2003) 1517-1525
45. Yamaguchi M. Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. Yakugaku Zasshi 126 11 (2006) 1117-1137
46. Yasuda T., and Ohsawa K. Urinary metabolites of daidzin orally administered in rats. Biol. Pharm. Bull. 21 9 (1998) 953-957
47. Ye S.F., Saga I., Ichimura K., Nagai T., Shinoda M., and Matsuzaki S. Coumestrol as well as isoflavones in soybean extract prevent bone resorption in ovariectomized rats. Endocr. Regul. 37 3 (2003) 145-152